Content
What infection risk in general and, specifically, which targeted therapies are important for the following risk groups: patients with Asthma, COPD or allergies?
- Virology
- Allergies
- Asthma
- COPD
Experts
- Prof. Dr. Mathias Pletz, Jena
Chair / Institue for Infectiology and Hospital Hygiene, University Hospital Jena - Prof. Dr. Oliver Pfaar, Marburg
Chair/ Section of Rhinology and Allergy
Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Marburg, Philipps-Universität Marburg
DGAKI): ext. Board of Directors - Prof. Dr. Claus Vogelmeier, Marburg
Department of Medicine, Pulmonary and Critical Care Medicine
University Medical Center Giessen and Marburg, Philipps-Universität Marburg, Germany
Global Initiative for Chronic Obstructive Lung Disease (GOLD) - Prof. Dr. Roland Buhl
Head of the Pulmonary Department at Mainz University Hospital
Global Initiative for Asthma (GINA)
Host
- Prof. Roland Buhl, Mainz
Date
09.04.2020, 8:00-9:30 pm (CET)
The broadcast will be highly interactive allowing you, the viewer, to send questions directly to the experts via Livechat, which is sure to guarantee lively discussions.